Evaluation of N-alkyl isatins and indoles as acetylcholinesterase and butyrylcholinesterase inhibitors.

IF 5.6 2区 医学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Journal of Enzyme Inhibition and Medicinal Chemistry Pub Date : 2024-12-01 Epub Date: 2023-12-07 DOI:10.1080/14756366.2023.2286935
Kaitlyn N Alcorn, Isabelle A Oberhauser, Matthew D Politeski, Todd J Eckroat
{"title":"Evaluation of <i>N</i>-alkyl isatins and indoles as acetylcholinesterase and butyrylcholinesterase inhibitors.","authors":"Kaitlyn N Alcorn, Isabelle A Oberhauser, Matthew D Politeski, Todd J Eckroat","doi":"10.1080/14756366.2023.2286935","DOIUrl":null,"url":null,"abstract":"<p><p>Two series of <i>N</i>-alkyl isatins and <i>N</i>-alkyl indoles varying in size of the alkyl group were synthesised and evaluated for inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE). Among the <i>N</i>-alkyl isatins <b>4a</b>-<b>j</b>, the addition of the <i>N</i>-alkyl group improved inhibition potency towards AChE and BChE compared to isatin. Selectivity towards inhibition of BChE was observed, and the increase in size of the <i>N</i>-alkyl group positively correlated to improved inhibition potency. The most potent inhibitor for BChE was <b>4i</b> (IC<sub>50</sub> = 3.77 µM, 22-fold selectivity for BChE over AChE). N-alkyl indoles <b>5a</b>-<b>j</b> showed similar inhibition of AChE, the most potent being <b>5g</b> (IC<sub>50</sub> = 35.0 µM), but <b>5a</b>-<b>j</b> lost activity towards BChE. This suggests an important role of the 3-oxo group on isatin for BChE inhibition, and molecular docking of <b>4i</b> with human BChE indicates a key hydrogen bond between this group and Ser198 and His438 of the BChE catalytic triad.</p>","PeriodicalId":15769,"journal":{"name":"Journal of Enzyme Inhibition and Medicinal Chemistry","volume":null,"pages":null},"PeriodicalIF":5.6000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Enzyme Inhibition and Medicinal Chemistry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/14756366.2023.2286935","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/12/7 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Two series of N-alkyl isatins and N-alkyl indoles varying in size of the alkyl group were synthesised and evaluated for inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE). Among the N-alkyl isatins 4a-j, the addition of the N-alkyl group improved inhibition potency towards AChE and BChE compared to isatin. Selectivity towards inhibition of BChE was observed, and the increase in size of the N-alkyl group positively correlated to improved inhibition potency. The most potent inhibitor for BChE was 4i (IC50 = 3.77 µM, 22-fold selectivity for BChE over AChE). N-alkyl indoles 5a-j showed similar inhibition of AChE, the most potent being 5g (IC50 = 35.0 µM), but 5a-j lost activity towards BChE. This suggests an important role of the 3-oxo group on isatin for BChE inhibition, and molecular docking of 4i with human BChE indicates a key hydrogen bond between this group and Ser198 and His438 of the BChE catalytic triad.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
n -烷基异黄酮和吲哚作为乙酰胆碱酯酶和丁基胆碱酯酶抑制剂的评价。
合成了两个不同烷基大小的n -烷基isatins和n -烷基吲哚,并对乙酰胆碱酯酶(AChE)和丁基胆碱酯酶(BChE)的抑制作用进行了评价。在n -烷基isatins 4a-j中,与isatin相比,n -烷基基团的加入提高了对AChE和BChE的抑制能力。观察到对BChE的抑制选择性,并且n -烷基基团大小的增加与抑制效力的提高正相关。对BChE最有效的抑制剂为4i (IC50 = 3.77µM,选择性为AChE的22倍)。n -烷基吲哚5a-j对乙酰胆碱酯(AChE)的抑制作用相似,IC50为35.0µM,最大抑制作用为5g,但对BChE的抑制作用减弱。这表明3-氧基在isatin抑制BChE中起重要作用,4i与人BChE的分子对接表明该基团与BChE催化三联体的Ser198和His438之间存在关键氢键。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
10.30
自引率
10.70%
发文量
195
审稿时长
4-8 weeks
期刊介绍: Journal of Enzyme Inhibition and Medicinal Chemistry publishes open access research on enzyme inhibitors, inhibitory processes, and agonist/antagonist receptor interactions in the development of medicinal and anti-cancer agents. Journal of Enzyme Inhibition and Medicinal Chemistry aims to provide an international and interdisciplinary platform for the latest findings in enzyme inhibition research. The journal’s focus includes current developments in: Enzymology; Cell biology; Chemical biology; Microbiology; Physiology; Pharmacology leading to drug design; Molecular recognition processes; Distribution and metabolism of biologically active compounds.
期刊最新文献
Evaluation of N-alkyl isatins and indoles as acetylcholinesterase and butyrylcholinesterase inhibitors. Identification of putative allosteric inhibitors of BCKDK via virtual screening and biological evaluation. Novel dual-targeting inhibitors of NSD2 and HDAC2 for the treatment of liver cancer: structure-based virtual screening, molecular dynamics simulation, and in vitro and in vivo biological activity evaluations. Searching for novel MDM2/MDMX dual inhibitors through a drug repurposing approach. Suppression of lipopolysaccharide-induced COX-2 expression via p38MAPK, JNK, and C/EBPβ phosphorylation inhibition by furomagydarin A, a benzofuran glycoside from Magydaris pastinacea.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1